Dear ID-IRI Members,
We are pleased to share an overview of the 2023 activities conducted by ID-IRI. Below, you’ll find a list of projects recently published or currently underway:
Published ID-IRI Projects in 2023:
- Investigation on clinical outcomes and factors impacting mortality in intensive care unit patients with COVID-19-associated Candidemia. (Mycoses, In press)
- Prospective analysis of febrile neutropenia patients with bacteraemia: The findings from the ID-IRI study. (International Journal of Antimicrobial Agents 2023; 7;62(3):106919)
- Clinicopathological profile of peritoneal tuberculosis and the introduction of a novel scoring model for predicting mortality: An international ID-IRI study. (European Journal of Clinical Microbiology and Infectious Diseases 2023;42(8):981-992)
- Investigating infectious causes of fever of unknown origin in developing countries: An international ID-IRI Study. (Journal of Intensive Medicine, In press)
- Examination of Classical Fever of Unknown Origin across 21 countries with varying economic development: An International ID-IRI Study. (European Journal of Clinical Microbiology and Infectious Diseases 2023;42(4):387-398)
- Analysis of features related to Mpox Infection based on data submitted to the ID-IRI network. (New Microbes and New Infections 2023;53:101154)
Ongoing ID-IRI Projects:
- Prospective observational international study on surgical site infections after cardiac surgery. This project is nearing completion and will soon be distributed to participants.
- Investigations on COVID-19-associated Mucormycosis Paper has been submitted elsewhere.
- COVID-19-associated Aspergillosis. Paper has been submitted elsewhere.
- Research on Primary Brain Abscesses – Data analysis is ongoing.
- Collection of data on PCP pneumonia continues.
- Ongoing data collection for the Stenotrophomonas Study.
Thank you for your ongoing dedication and contributions to these crucial endeavors. Best wishes